GGrantIndex
← Leaderboards

Giovanni Schifitto

University Of Rochester

Google Scholar ↗PubMed ↗ORCID ↗
$20,832,433
Attributed
$26,164,045
Total exposure
21
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY2005–25
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$26,164,045 · 21

By mechanism

R01$19,972,175 · 7
U01$3,956,986 · 2
P50$766,932 · 1
R21$724,169 · 2
P01$533,262 · 1
M01$210,521 · 8

Top collaborators

Most similar at University Of Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Hiv Infections”

Research focus

Hiv InfectionsAffectPlasmaBrainBaseImageReportingInflammatoryAntiretroviral TherapyImpaired CognitionAgingChronicCohortWhite MatterMonocyteLeadParticipantCerebral Small Vessel DiseaseCentral Nervous System InjuryMagnetic Resonance ImagingClinical ResearchMediatingCerebrovascular DisordersPlay

Grant awards (59)

Role of Monocyte Delta Like-4 (Dll4) in HIV-Associated Cerebral Small Vessel Disease$756,784
R01 · FY2025 · NS · contact PI
Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults$718,089
R01 · FY2025 · AG · contact PI
Role of Monocyte Delta Like-4 (Dll4) in HIV-Associated Cerebral Small Vessel Disease$757,725
R01 · FY2024 · NS · contact PI
Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults$740,897
R01 · FY2024 · AG · contact PI
Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults$750,331
R01 · FY2023 · AG · contact PI
Brain Structural and Functional Connectome in HIV-associated Neuroinflammation$552,227
R01 · FY2023 · MH · contact PI
Brain Structural and Functional Connectome in HIV-Associated Neuroinflammation$382,639
R01 · FY2023 · MH · contact PI
Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults$745,511
R01 · FY2022 · AG · contact PI
Brain Structural and Functional Connectome in HIV-associated Neuroinflammation$553,084
R01 · FY2022 · MH · contact PI
Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART$145,800
R21 · FY2022 · TW
The Clinical Core will support in-person and virtual research visits for three of the four Research Projects at the University of Rochester Udall Center$120,342
P50 · FY2022 · NS · contact PI
Role of Myeloid Cells in Cerebrovascular Permeability and Reactivity in Older HIV Infected Individuals$696,405
R01 · FY2021 · AG · contact PI
Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART$156,536
R21 · FY2021 · TW
The Clinical Core will support in-person and virtual research visits for three of the four Research Projects at the University of Rochester Udall Center$120,342
P50 · FY2021 · NS · contact PI
Role of Myeloid Cells in Cerebrovascular Permeability and Reactivity in Older HIV Infected Individuals$702,057
R01 · FY2020 · AG · contact PI
Brain Structural and Functional Connectome in HIV-associated Neuroinflammation$553,751
R01 · FY2020 · MH · contact PI
Brain Structural and Functional Connectome in HIV-associated Neuroinflammation$279,390
R01 · FY2020 · MH · contact PI
HIV neuroinflammation alters brain microstructure and viscoelastic properties$199,114
R21 · FY2020 · NS · contact PI
The Clinical Core will support in-person and virtual research visits for three of the four Research Projects at the University of Rochester Udall Center$120,342
P50 · FY2020 · NS · contact PI
Role of Myeloid Cells in Cerebrovascular Permeability and Reactivity in Older HIV Infected Individuals$705,838
R01 · FY2019 · AG · contact PI
Brain Structural and Functional Connectome in HIV-associated Neuroinflammation$576,762
R01 · FY2019 · MH · contact PI
HIV neuroinflammation alters brain microstructure and viscoelastic properties$222,719
R21 · FY2019 · NS · contact PI
The Clinical Core will support in-person and virtual research visits for three of the four Research Projects at the University of Rochester Udall Center$133,683
P50 · FY2019 · NS · contact PI
PAR 13-233 cART accelerates vascular aging in HIV infected subjects$720,374
R01 · FY2018 · HL · contact PI
Role of Myeloid Cells in Cerebrovascular Permeability and Reactivity in Older HIV Infected Individuals$711,488
R01 · FY2018 · AG · contact PI
Brain Structural and Functional Connectome in HIV-associated Neuroinflammation$541,975
R01 · FY2018 · MH · contact PI
The Clinical Core will support in-person and virtual research visits for three of the four Research Projects at the University of Rochester Udall Center$272,223
P50 · FY2018 · NS · contact PI
PAR 13-233 cART accelerates vascular aging in HIV infected subjects$729,804
R01 · FY2017 · HL · contact PI
Role of Myeloid Cells in Cerebrovascular Permeability and Reactivity in Older HIV Infected Individuals$715,820
R01 · FY2017 · AG · contact PI
Chronic Exposure to cART Predispose Older HIV Infected Individuals to CNS Injury?$516,104
R01 · FY2017 · MH · contact PI
PAR 13-233 cART accelerates vascular aging in HIV infected subjects$733,113
R01 · FY2016 · HL · contact PI
Chronic Exposure to cART Predispose Older HIV Infected Individuals to CNS Injury?$571,985
R01 · FY2016 · MH · contact PI
Creatine Safety and Efficacy in HD: Coordination and Statistical Center$122,800
U01 · FY2016 · AT · contact PI
Creatine Safety and Efficacy in HD: Coordination and Statistical Center$926,394
U01 · FY2015 · AT · contact PI
PAR 13-233 cART accelerates vascular aging in HIV infected subjects$739,353
R01 · FY2015 · HL · contact PI
Chronic Exposure to cART Predispose Older HIV Infected Individuals to CNS Injury?$618,627
R01 · FY2015 · MH · contact PI
Creatine Safety and Efficacy in HD: Coordination and Statistical Center$1,000,000
U01 · FY2014 · AT · contact PI
PAR 13-233 cART accelerates vascular aging in HIV infected subjects$747,059
R01 · FY2014 · HL · contact PI
Chronic Exposure to cART Predispose Older HIV Infected Individuals to CNS Injury?$641,768
R01 · FY2014 · MH · contact PI
Creatine Safety and Efficacy in HD: Coordination and Statistical Supplement$869,511
U01 · FY2013 · AT · contact PI
Chronic Exposure to cART Predispose Older HIV Infected Individuals to CNS Injury?$603,899
R01 · FY2013 · MH · contact PI
Creatine Safety and Efficacy in HD: Coordination and Statistical Center$1,038,281
U01 · FY2010 · AT · contact PI
PHASE IB VALPROIC ACID STUDY FOR HIV-ASSOCIATED COGNITIVE IMPAIRMENT$61,647
M01 · FY2005 · RR
EVALUATION OF POSAPTIDE FOR RELIEF OF NEUROPATHIC PAIN ASSOCIATED WITH HIV$12,781
M01 · FY2005 · RR
PHASE IB VALPROIC ACID STUDY FOR HIV DEMENTIA$43,266
M01 · FY2004 · RR
NEUROCOGNITIVE FUNCTION, HIV LOAD AND SURROGATE MARKERS$24,405
M01 · FY2004 · RR
HIV ASSOCIATED PAINFUL DISTAL SENSORY NEUROPATHY, HIV RNA LOAD$24,405
M01 · FY2004 · RR
PHASE I TRIALS UNIT FOR COGNITIVE IMPAIRMENT IN HIV$9,984
M01 · FY2004 · RR
EVALUATION OF PROSAPTIDE FOR RELIEF OF NEUROPATHIC PAIN$9,984
M01 · FY2004 · RR
AGING AND HIV ASSOCIATED NEUROLOGICAL COMPLICATIONS$4,436
M01 · FY2004 · RR
Selegiline, Oxidative Stress and MRS in HIV Dementia$549,520
R01 · FY2003 · MH
Selegiline, Oxidative Stress and MRS in HIV Dementia$659,193
R01 · FY2002 · MH
Phase I trials unit for cognitive impairment in HIV$266,631
P01 · FY2002 · MH
Phase I trials unit for cognitive impairment in HIV$266,631
P01 · FY2002 · MH
S&E STUDY OF CPI 1189 IN HIV INFECTED INDIVIDUALS W/ COGNITIVE IMPAIR$0
M01 · FY2002 · RR
Selegiline, Oxidative Stress and MRS in HIV Dementia$700,603
R01 · FY2001 · MH
EVALUATION OF AUTONOMIC NERVOUS SYSTEM IN HIV POSITIVE INDIVIDUALS$19,613
M01 · FY2001 · RR
Phase I trials unit for cognitive impairment in HIV$0
P01 · FY2001 · MH
S&E STUDY OF CPI 1189 IN HIV INFECTED INDIVIDUALS W/ COGNITIVE IMPAIR$0
M01 · FY2000 · RR